Portfolio Holdings Detail for ISIN IE00BFNM3H51
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares MSCI USA ESG Screened UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerSDUS(USD) LSE
ETF TickerSLUS(EUR) F
ETF TickerSDUS.LS(USD) CXE
ETF TickerSLUS.DE(EUR) CXE
ETF TickerSDUS.L(GBP) LSE

Holdings detail for INCY

Stock NameIncyte Corporation
TickerINCY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45337C1027
LEI549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib
(RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update
Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY)
Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00
Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY)
Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC
Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)
Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)
Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY)
Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY)
State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY)
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY)
Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY)
Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus
Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares MSCI USA ESG Screened UCITS ETF USD (Dist) INCY holdings

DateNumber of INCY Shares HeldBase Market Value of INCY SharesLocal Market Value of INCY SharesChange in INCY Shares HeldChange in INCY Base ValueCurrent Price per INCY Share HeldPrevious Price per INCY Share Held
2025-12-02 (Tuesday)51,933INCY holding decreased by -90USD 5,268,084INCY holding decreased by -40343USD 5,268,084-90USD -40,343 USD 101.44 USD 102.04
2025-12-01 (Monday)52,023INCY holding increased by 970USD 5,308,427INCY holding decreased by -24569USD 5,308,427970USD -24,569 USD 102.04 USD 104.46
2025-11-28 (Friday)51,053INCY holding increased by 98USD 5,332,996INCY holding decreased by -50400USD 5,332,99698USD -50,400 USD 104.46 USD 105.65
2025-11-27 (Thursday)50,955USD 5,383,396USD 5,383,3960USD 0 USD 105.65 USD 105.65
2025-11-26 (Wednesday)50,955INCY holding decreased by -30USD 5,383,396INCY holding increased by 1929USD 5,383,396-30USD 1,929 USD 105.65 USD 105.55
2025-11-25 (Tuesday)50,985INCY holding increased by 170USD 5,381,467INCY holding decreased by -17119USD 5,381,467170USD -17,119 USD 105.55 USD 106.24
2025-11-24 (Monday)50,815INCY holding increased by 320USD 5,398,586INCY holding increased by 245066USD 5,398,586320USD 245,066 USD 106.24 USD 102.06
2025-11-21 (Friday)50,495INCY holding increased by 55USD 5,153,520INCY holding increased by 20746USD 5,153,52055USD 20,746 USD 102.06 USD 101.76
2025-11-20 (Thursday)50,440INCY holding increased by 11USD 5,132,774INCY holding increased by 23308USD 5,132,77411USD 23,308 USD 101.76 USD 101.32
2025-11-19 (Wednesday)50,429INCY holding increased by 63USD 5,109,466INCY holding decreased by -123058USD 5,109,46663USD -123,058 USD 101.32 USD 103.89
2025-11-18 (Tuesday)50,366INCY holding increased by 198USD 5,232,524INCY holding increased by 6523USD 5,232,524198USD 6,523 USD 103.89 USD 104.17
2025-11-17 (Monday)50,168INCY holding increased by 80USD 5,226,001INCY holding increased by 9336USD 5,226,00180USD 9,336 USD 104.17 USD 104.15
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00BFNM3H51

Show aggregate share trades of INCY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02SELL-90103.540100.550 100.849USD -9,076 74.22 Loss of -2,396 on sale
2025-12-01BUY970103.890101.470 101.712USD 98,660 74.10
2025-11-28BUY98106.990103.850 104.164USD 10,208 73.96
2025-11-26SELL-30107.000105.085 105.276USD -3,158 73.67 Loss of -948 on sale
2025-11-26SELL-30107.000105.085 105.276USD -3,158 73.67 Loss of -948 on sale
2025-11-25BUY170107.605105.160 105.405USD 17,919 73.53
2025-11-24BUY320106.670102.503 102.920USD 32,934 73.37
2025-11-21BUY55103.200101.400 101.580USD 5,587 73.24
2025-11-20BUY11103.225101.080 101.295USD 1,114 73.11
2025-11-19BUY63104.660100.300 100.736USD 6,346 72.98
2025-11-18BUY198107.265103.790 104.137USD 20,619 72.83
2025-11-17BUY80105.970103.830 104.044USD 8,324 72.68
2025-11-14SELL-60106.920103.770 104.085USD -6,245 72.54 Loss of -1,893 on sale
2025-11-12BUY360109.275106.810 107.056USD 38,540 72.21
2025-11-10BUY193108.810104.070 104.544USD 20,177 71.87
2025-11-07SELL-12106.400103.810 104.069USD -1,249 71.70 Loss of -388 on sale
2025-11-06SELL-40106.430103.075 103.410USD -4,136 71.54 Loss of -1,275 on sale
2025-11-05BUY130106.470101.500 101.997USD 13,260 71.37
2025-11-04BUY160103.860100.020 100.404USD 16,065 71.22
2025-11-03SELL-88101.79091.160 92.223USD -8,116 71.07 Loss of -1,862 on sale
2025-10-30BUY55094.62091.190 91.533USD 50,343 70.85
2025-10-29BUY55090.18094.420 93.996USD 51,698 70.75
2025-10-28BUY5591.65093.980 93.747USD 5,156 70.65
2025-10-27BUY3393.08093.170 93.161USD 3,074 70.53
2025-10-24BUY2291.28092.080 92.000USD 2,024 70.43
2025-10-21BUY3387.30087.480 87.462USD 2,886 70.15
2025-10-20BUY12186.17087.950 87.772USD 10,620 70.07
2025-10-16BUY11087.31092.860 92.305USD 10,154 69.88
2025-10-15BUY13088.15088.490 88.456USD 11,499 69.79
2025-10-02BUY8086.28088.660 88.422USD 7,074 69.61
2025-10-01BUY12486.70087.240 87.186USD 10,811 69.52
2025-09-30BUY73084.81085.310 85.260USD 62,240 69.44
2025-09-29BUY19083.89084.410 84.358USD 16,028 69.36
2025-09-26BUY43082.70082.950 82.925USD 35,658 69.29
2025-09-25BUY3081.66084.450 84.171USD 2,525 69.22
2025-09-18BUY12086.00086.070 86.063USD 10,328 69.13
2025-09-17BUY15084.80085.980 85.862USD 12,879 69.04
2025-09-16BUY24083.90084.580 84.512USD 20,283 68.96
2025-08-19SELL-9685.46085.690 85.667USD -8,224 68.86 Loss of -1,613 on sale
2025-08-15BUY2486.92087.060 87.046USD 2,089 68.67
2025-08-13BUY1385.85086.020 86.003USD 1,118 68.57
2025-08-08BUY10778.39079.000 78.939USD 8,446 68.51
2025-08-06BUY22677.65079.430 79.252USD 17,911 68.40
2025-07-31BUY6574.89077.460 77.203USD 5,018 68.31
2025-07-29BUY26077.38077.870 77.821USD 20,233 68.20
2025-07-11BUY10468.59069.970 69.832USD 7,263 68.20
2025-07-10BUY11770.34070.620 70.592USD 8,259 68.19
2025-07-09BUY11768.72069.300 69.242USD 8,101 68.18
2025-07-07SELL-7867.27068.250 68.152USD -5,316 68.19 Profit of 3 on sale
2025-07-02SELL-32568.17069.100 69.007USD -22,427 68.19 Loss of -266 on sale
2025-06-27BUY3968.37071.120 70.845USD 2,763 68.19
2025-06-26BUY3970.81071.500 71.431USD 2,786 68.17
2025-06-24SELL-18269.01069.540 69.487USD -12,647 68.17 Loss of -239 on sale
2025-06-18BUY10468.27069.470 69.350USD 7,212 68.17
2025-06-17BUY3968.81070.890 70.682USD 2,757 68.17
2025-06-16SELL-5371.22071.290 71.283USD -3,778 68.15 Loss of -166 on sale
2025-06-12SELL-6569.22069.540 69.508USD -4,518 68.14 Loss of -89 on sale
2025-06-11BUY14368.85070.360 70.209USD 10,040 68.14
2025-06-06BUY3968.77068.980 68.959USD 2,689 68.11
2025-06-05BUY18267.24067.870 67.807USD 12,341 68.11
2025-06-04BUY2467.42068.450 68.347USD 1,640 68.12
2025-06-03SELL-1267.11070.970 70.584USD -847 68.13 Loss of -30 on sale
2025-05-30SELL-1,46465.06065.770 65.699USD -96,183 68.17 Profit of 3,614 on sale
2025-05-29BUY3666.04066.260 66.238USD 2,385 68.18
2025-05-27BUY20465.35065.800 65.755USD 13,414 68.23
2025-05-23BUY18064.25064.570 64.538USD 11,617 68.29
2025-05-22BUY8464.51065.330 65.248USD 5,481 68.32
2025-05-19BUY7263.81064.300 64.251USD 4,626 68.40
2025-05-16BUY3663.31063.480 63.463USD 2,285 68.44
2025-05-15SELL-2462.76062.990 62.967USD -1,511 68.48 Profit of 132 on sale
2025-05-14BUY1261.16062.500 62.366USD 748 68.54
2025-05-13BUY2460.81061.150 61.116USD 1,467 68.60
2025-05-12BUY6960.85061.410 61.354USD 4,233 68.67
2025-05-09SELL-6058.98060.480 60.330USD -3,620 68.74 Profit of 505 on sale
2025-05-08BUY2459.73059.990 59.964USD 1,439 68.82
2025-05-07BUY3659.55060.070 60.018USD 2,161 68.89
2025-05-02BUY1,33262.53062.870 62.836USD 83,698 69.08
2025-04-30BUY42062.66062.870 62.849USD 26,397 69.20
2025-04-29BUY10860.43060.720 60.691USD 6,555 69.27
2025-04-28BUY8459.52059.600 59.592USD 5,006 69.36
2025-04-25BUY21659.16059.210 59.205USD 12,788 69.45
2025-04-24SELL-25258.97059.050 59.042USD -14,879 69.54 Profit of 2,645 on sale
2025-04-23BUY22858.00059.010 58.909USD 13,431 69.64
2025-04-22BUY9657.38058.040 57.974USD 5,566 69.75
2025-04-17BUY13258.21058.690 58.642USD 7,741 70.09
2025-04-15BUY12058.46059.950 59.801USD 7,176 70.31
2025-04-11BUY20856.87057.070 57.050USD 11,866 70.55
2025-04-09BUY7258.86059.370 59.319USD 4,271 70.81
2025-04-08BUY43256.97061.470 61.020USD 26,361 70.95
2025-04-07BUY14460.29061.060 60.983USD 8,782 71.06
2025-04-04SELL-19260.58063.570 63.271USD -12,148 71.16 Profit of 1,515 on sale
2025-04-02BUY1,63262.33062.530 62.510USD 102,016 71.25
2025-04-01BUY1260.91062.000 61.891USD 743 71.36
2025-03-31BUY8460.55060.810 60.784USD 5,106 71.47
2025-03-28BUY4860.60060.970 60.933USD 2,925 71.59
2025-03-27BUY2460.68061.640 61.544USD 1,477 71.70
2025-03-26BUY1261.26062.880 62.718USD 753 71.82
2025-03-25BUY13262.08063.270 63.151USD 8,336 71.92
2025-03-24BUY15662.78063.310 63.257USD 9,868 72.02
2025-03-21SELL-4861.92062.330 62.289USD -2,990 72.13 Profit of 473 on sale
2025-03-20BUY19260.58061.750 61.633USD 11,834 72.26
2025-03-19BUY3660.34061.150 61.069USD 2,198 72.40
2025-03-18BUY43260.00061.030 60.927USD 26,320 72.54
2025-03-17BUY8462.01063.450 63.306USD 5,318 72.66
2025-03-14BUY62467.86068.120 68.094USD 42,491 72.72
2025-03-13BUY12067.71068.970 68.844USD 8,261 72.78
2025-03-12SELL-60067.73068.230 68.180USD -40,908 72.84 Profit of 2,797 on sale
2025-03-11SELL-44468.07071.650 71.292USD -31,654 72.90 Profit of 714 on sale
2025-03-10BUY13271.13071.890 71.814USD 9,479 72.92
2025-03-07BUY2470.79072.810 72.608USD 1,743 72.95
2025-03-05BUY18069.81069.970 69.954USD 12,592 72.99
2025-03-04BUY20469.68070.000 69.968USD 14,273 73.03
2025-03-03BUY38470.26073.450 73.131USD 28,082 73.07
2025-02-28BUY31273.50073.630 73.617USD 22,969 73.06
2025-02-27SELL-6073.18074.600 74.458USD -4,467 73.06 Loss of -84 on sale
2025-02-25BUY44474.40076.240 76.056USD 33,769 73.02
2025-02-21BUY4872.11072.970 72.884USD 3,498 73.02
2025-02-18SELL-10871.27071.680 71.639USD -7,737 73.11 Profit of 159 on sale
2025-02-14SELL-73270.42071.800 71.662USD -52,457 73.20 Profit of 1,123 on sale
2025-02-13BUY1270.01072.690 72.422USD 869 73.24
2025-02-12BUY11869.05069.100 69.095USD 8,153 73.31
2025-02-07SELL-1774.13076.960 76.677USD -1,304 73.49 Loss of -54 on sale
2025-02-06BUY22874.95075.490 75.436USD 17,199 73.47
2025-02-05BUY6075.26075.740 75.692USD 4,542 73.44
2025-02-04BUY7274.12074.920 74.840USD 5,388 73.43
2025-02-03BUY7273.74075.000 74.874USD 5,391 73.42
2025-01-31BUY13274.16075.180 75.078USD 9,910 73.41
2025-01-29SELL-1273.72074.110 74.071USD -889 73.40 Loss of -8 on sale
2025-01-28SELL-10873.15073.990 73.906USD -7,982 73.40 Loss of -55 on sale
2025-01-27SELL-19272.64073.430 73.351USD -14,083 73.42 Profit of 12 on sale
2025-01-24BUY14472.59073.680 73.571USD 10,594 73.43
2025-01-23BUY2472.53072.880 72.845USD 1,748 73.45
2024-12-10BUY60072.48073.100 73.038USD 43,823 73.47
2024-12-09BUY7272.11075.980 75.593USD 5,443 73.50
2024-12-06SELL-18075.92076.460 76.406USD -13,753 73.45 Loss of -533 on sale
2024-12-05SELL-1274.92075.370 75.325USD -904 73.41 Loss of -23 on sale
2024-12-03BUY6072.03072.960 72.867USD 4,372 73.42
2024-11-27SELL-7275.45076.140 76.071USD -5,477 73.29 Loss of -200 on sale
2024-11-26BUY25274.80074.950 74.935USD 18,884 73.25
2024-11-25BUY3373.52073.870 73.835USD 2,437 73.25
2024-11-22SELL-2471.72072.000 71.972USD -1,727 73.29 Profit of 32 on sale
2024-11-21SELL-6070.39071.400 71.299USD -4,278 73.37 Profit of 124 on sale
2024-11-20SELL-2471.05071.680 71.617USD -1,719 73.43 Profit of 44 on sale
2024-11-19BUY1270.56074.100 73.746USD 885 73.52
2024-11-18BUY10876.97077.010 77.006USD 8,317 73.41
2024-11-11BUY3681.53083.540 83.339USD 3,000 72.63
2024-11-11BUY3681.53083.540 83.339USD 3,000 72.63
2024-11-07BUY3282.34082.970 82.907USD 2,653 71.06
2024-11-07BUY3282.34082.970 82.907USD 2,653 71.06
2024-11-06BUY28880.95082.190 82.066USD 23,635 70.24
2024-11-06BUY28880.95082.190 82.066USD 23,635 70.24
2024-11-05BUY6077.28077.370 77.361USD 4,642 69.60
2024-11-05BUY6077.28077.370 77.361USD 4,642 69.60
2024-11-04BUY2275.75076.570 76.488USD 1,683 68.98
2024-11-04BUY2275.75076.570 76.488USD 1,683 68.98
2024-11-01BUY3376.13076.330 76.310USD 2,518 68.19
2024-11-01BUY3376.13076.330 76.310USD 2,518 68.19
2024-10-30SELL-7273.93074.600 74.533USD -5,366 66.52 Loss of -577 on sale
2024-10-30SELL-7273.93074.600 74.533USD -5,366 66.52 Loss of -577 on sale
2024-10-29SELL-21673.60074.070 74.023USD -15,989 65.34 Loss of -1,876 on sale
2024-10-29SELL-21673.60074.070 74.023USD -15,989 65.34 Loss of -1,876 on sale
2024-10-28SELL-8465.69065.880 65.861USD -5,532 65.27 Loss of -50 on sale
2024-10-28SELL-8465.69065.880 65.861USD -5,532 65.27 Loss of -50 on sale
2024-10-21SELL-1265.27066.550 66.422USD -797 0.00 Loss of -797 on sale
2024-10-21SELL-1265.27066.550 66.422USD -797 0.00 Loss of -797 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19321,923395451,11071.4%
2025-09-18244,9471,423469,74752.1%
2025-09-17277,858779546,95350.8%
2025-09-16359,781946576,37962.4%
2025-09-15347,4534582,22859.7%
2025-09-12353,0400631,53455.9%
2025-09-11448,7333,894739,70160.7%
2025-09-10490,727248671,93273.0%
2025-09-09515,3951,822682,79175.5%
2025-09-08308,184119479,82864.2%
2025-09-05256,7192,505512,04950.1%
2025-09-04422,6241,507834,71750.6%
2025-09-03381,6797,777624,92261.1%
2025-09-02547,12015,396816,26767.0%
2025-08-29148,294262304,42748.7%
2025-08-28164,0080347,48047.2%
2025-08-27248,926453513,40148.5%
2025-08-26365,1306709,32051.5%
2025-08-25478,1301,306642,31974.4%
2025-08-22344,3522,023596,30157.7%
2025-08-21198,7294,881335,30159.3%
2025-08-20351,6993,977555,34563.3%
2025-08-19343,1103,146574,32859.7%
2025-08-18366,1244,996653,10356.1%
2025-08-15480,8858,035625,79776.8%
2025-08-14593,55436,654806,06873.6%
2025-08-13845,18198,1601,257,50367.2%
2025-08-12462,89642,208678,68968.2%
2025-08-11385,211696595,89264.6%
2025-08-08248,925738426,18758.4%
2025-08-07268,864929420,48663.9%
2025-08-06554,642891731,48475.8%
2025-08-05361,6872,092623,87958.0%
2025-08-04338,0051,464519,15065.1%
2025-08-01414,814828572,87972.4%
2025-07-31570,8456,148777,41773.4%
2025-07-30471,30314,166881,19453.5%
2025-07-29966,64010,5811,593,70160.7%
2025-07-28382,23662625,51061.1%
2025-07-25216,96749422,99051.3%
2025-07-24348,27623528,51765.9%
2025-07-23297,903583487,29761.1%
2025-07-22267,987172446,48960.0%
2025-07-21223,626380406,72955.0%
2025-07-18241,218108471,58951.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy